Objectives: To investigate the current situation of using drugs to treat gastroenteritis of outpatients at the gastrointestinal department of Vinh Long General Hospital. Subjects and methods: Study of retrospective cross- sectional description on 310 medical records of patients over 18 years old diagnosed with gastroenteritis, outpatient treatment at the internal department, Vinh Long General Hospital from November 2019 to July 2020. Results: Patients using PPI drugs in gastroenteritis accounted for 95.16%, of which Esomeprazole was used the most 38.39%, rabeprazole accounted for 31.94%, lansoprazole accounted for 11.94%, pantoprazole 3.87%. Most of the patients were used in combination with supportive drug treatment. The group of antiemetic drugs, reduce flatulence used with a high rate of 59.68%, the group of mucosal protection drugs accounted for 54.84%. The most common side effects were mild, with 9.35%. Conclusion: Patients using PPI drugs in gastroenteritis accounted for 95.16%, rarely encounter drug interactions and side effects.
CURRENT SITUATION OF MEDICINES USED IN THE TREATMENT OF GATROENTERITIS
49
Views
17
Downloads
Keywords
Gastroenteritis, current situation of drug use.
Abstract
References
[1]
Trường đại học Dược Hà Nội (2007), Dược lâm sàng và điều trị, NXB Y học: 262-271.
Google Scholar
[2]
Trường đại học Y Hà Nội (2014), Dược lý học lâm sàng, NXB Y học.
Google Scholar
[3]
Trịnh Thị Nhiên (2016). Khảo sát tình hình sử dụng các thuốc trị viêm loét dạ dày, tá tràng trong điều trị nội
Google Scholar
[4]
trú tại Bệnh viện đa khoa khu vực cái nước năm 2015. Bệnh viện Đa khoa Cái Nước.
Google Scholar
[5]
Fock KM, Ang TL (2010). Epidemiology of Helicobacter pylori infection and gastric cancer in Asia. J
Google Scholar
[6]
Gastroenterol Hepatol, 25: 479–486
Google Scholar
[7]
Malfertheiner P, Megraud F, O’Morain C et al (2012). Management of Helicobacter pylori infection: the
Google Scholar
[8]
Maastricht IV Consensus Report. Gut, 61(5): 646-664.
Google Scholar
[9]
Daniel S Strand, Daejin Kim, David A Peura (2017). 25 years of proton pump inhibitors: a comprehensive
Google Scholar
[10]
review. Gut and liver, 11(1): 27.
Google Scholar
[11]
Fallone CA, Chiba N, Van Zanten SV et al (2016). The Toronto Consensus for the treatment of Helicobacter
Google Scholar
[12]
pylori infection in adults. Gastroenterology, 151: 51-69.
Google Scholar
[13]
Yuan Y, Ford AC, Khan KJ et al (2013). Optimum duration of regimens for Helicobacter pylori eradication.
Google Scholar
[14]
Cochrane Database Syst Rev, 12: CD008337.
Google Scholar